Disturbance in calcium (Ca2+) homeostasis has been involved in a variety of neuropathological conditions including Parkinson's disease (PD). The Ca2+ channel, transient receptor potential channel 1 (TRPC1), plays a protective role in regulating entry of Ca2+ activated by store depletion of Ca2+ in endoplasmic reticulum (ER). We have showed that thioredoxin‐1 (Trx‐1) plays a role in suppressing ER stress in PD. However, whether Trx‐1 regulates TRPC1 expression in PD is still unknown. In the present study, we demonstrated that treatment of 1‐methyl‐4‐phenylpyridinum ion (MPP+) significantly reduced the expression of TRPC1 in PC12 cells, which was restored by Trx‐1 overexpression, and further decreased significantly by Trx‐1 siRNA. Moreover, we found that Ca2+ entered into the cells was decreased by MPP+ in PC 12 cells, which was restored by Trx‐1 overexpression, and further decreased by Trx‐1 siRNA. MPP+ significantly increased calcium‐dependent cysteine protease calpain1 expression in PC12 cells, which was suppressed by Trx‐1 overexpression. Calpain1 expression was increased by Trx‐1 siRNA or SKF96365, an inhibitor of TRPC1. Moreover, 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) decreased TRPC1 expression in the substantia nigra pars compacta region (SNpc), which was restored in mice overexpressing Trx‐1, and further decreased in mice of knockdown Trx‐1. Inversely, the expression of calpain1 was increased by MPTP, which was suppressed in mice overexpressing Trx‐1, and further increased in mice of knockdown Trx‐1.
In conclusion, Trx‐1 regulates the Ca2+ entry through regulating TRPC1 expression after treatment of MPP+/MPTP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.